RY 173.53 0.0461% SHOP 159.5 1.56% TD 76.22 0.8068% ENB 60.09 0.0333% BN 82.79 0.988% TRI 234.13 -0.1706% CNQ 43.47 0.6949% CP 105.63 0.4756% CNR 148.07 0.5637% BMO 139.11 -0.2152% BNS 77.03 -0.0649% CSU 4547.4502 0.8243% CM 92.53 0.2383% MFC 44.05 0.0454% ATD 80.59 0.1989% NGT 54.92 0.1459% TRP 66.54 0.2561% SU 50.61 0.4765% WCN 248.6 1.1885% L 191.07 -0.4325%

Cellebrite DI

Technology US CLBT

22.4825USD
0.03(0.12%)

Last update at 2024-12-26T16:45:00Z

Day Range

22.2722.63
LowHigh

52 Week Range

7.9121.72
LowHigh

Fundamentals

  • Previous Close 22.45
  • Market Cap4271.08M
  • Volume192494
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA67.17M
  • Revenue TTM385.17M
  • Revenue Per Share TTM1.93
  • Gross Profit TTM 219.91M
  • Diluted EPS TTM-1.58

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax 120.76M 82.31M 11.40M 1.42M
Minority interest - - - -
Net income 120.81M 71.40M 5.78M -1.87600M
Selling general administrative 40.85M 47.94M 29.86M 28.62M
Selling and marketing expenses 97.39M 76.39M 61.30M 61.61M
Gross profit 219.91M 203.69M 157.03M 136.03M
Reconciled depreciation 9.19M 7.09M 5.88M 4.08M
Ebit 1.04M 13.82M 9.22M -1.33200M
Ebitda 10.24M 20.91M 15.54M 2.75M
Depreciation and amortization 9.19M 7.09M 6.33M 4.08M
Non operating income net other - - - -
Operating income 1.04M 13.82M 9.22M -1.33200M
Other operating expenses 269.61M 232.42M 185.69M 173.37M
Interest expense 119.72M 68.48M 1.73M 2.75M
Tax provision -0.04500M 10.91M 5.62M 3.29M
Interest income 1.60M 68.48M 2.18M 2.94M
Net interest income 119.72M 68.48M 2.18M 2.94M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense -0.04500M 10.91M 5.62M 3.29M
Total revenue 270.65M 246.25M 194.91M 171.85M
Total operating expenses 218.86M 189.87M 147.82M 137.55M
Cost of revenue 50.75M 42.56M 37.88M 35.82M
Total other income expense net 119.72M 68.48M 2.18M 2.75M
Discontinued operations - - - -
Net income from continuing ops 120.81M 71.40M 5.78M -1.87600M
Net income applicable to common shares 120.81M 70.43M -9.34400M -10.03900M
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 540.40M 403.29M 339.78M 364.39M 280.24M
Intangible assets 10.59M 11.25M 11.23M 6.61M -
Earning assets - - - - -
Other current assets 25.80M 17.09M 12.82M 2.96M 1.66M
Total liab 506.19M 329.43M 413.13M 300.58M 221.41M
Total stockholder equity 34.21M 73.86M -73.34900M 63.80M 58.83M
Deferred long term liab - - - - -
Other current liab 43.98M 45.45M 54.04M 48.55M 24.01M
Common stock - - - - -
Capital stock 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Retained earnings 118.14M 199.24M 78.44M 28.34M 32.56M
Other liab - 111.30M 226.56M 40.00M 21.05M
Good will 26.83M 26.83M 26.83M 9.46M 0.00000M
Other assets - 14.24M 11.76M 7.94M 3.53M
Cash 189.52M 87.64M 145.97M 128.71M 76.55M
Cash and equivalents - - - - -
Total current liabilities 253.82M 207.78M 186.57M 159.38M 99.16M
Current deferred revenue 196.59M 152.71M 122.98M 106.10M 69.79M
Net debt -175.38800M -72.28900M -145.97300M -128.70900M -76.54600M
Short term debt 4.97M 5.00M - - -
Short long term debt - - - - -
Short long term debt total 14.13M 15.36M - - -
Other stockholder equity -84.98100M -125.70900M -153.15700M 34.14M 25.46M
Property plant equipment - 32.91M 16.76M 16.11M 14.82M
Total current assets 416.53M 295.93M 273.21M 324.27M 261.88M
Long term investments 28.86M 22.12M - - -
Net tangible assets - 35.78M -111.40400M 47.73M 58.83M
Short term investments 113.41M 95.98M 35.59M 108.93M 123.71M
Net receivables 77.27M 78.76M 67.50M 66.32M 44.24M
Long term debt - - - - -
Inventory 10.54M 10.18M 6.51M 4.75M 3.96M
Accounts payable 8.28M 4.61M 9.55M 4.73M 5.36M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.05M 0.33M 1.37M 1.32M 0.80M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 12.89M 1.73M 1.96M 0.56M 0.45M
Deferred long term asset charges - - - - -
Non current assets total 123.86M 107.36M 66.57M 40.12M 18.36M
Capital lease obligations 14.13M 15.36M - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -91.23100M 73.34M 14.78M -40.51300M
Change to liabilities 33.49M 26.04M 46.30M 16.82M
Total cashflows from investing activities -91.23100M 45.23M -6.44900M -46.72200M
Net borrowings - - - -
Total cash from financing activities 13.97M -68.39700M -8.59300M 75.54M
Change to operating activities -19.74900M -1.60700M 23.83M -2.55100M
Net income 120.81M 71.40M 5.78M -1.87600M
Change in cash -58.32800M 12.13M 52.16M 44.88M
Begin period cash flow 145.97M 133.85M 81.68M 36.80M
End period cash flow 87.64M 145.97M 133.85M 81.68M
Total cash from operating activities 20.58M 36.05M 66.51M 16.13M
Issuance of capital stock - 0.00000M - 101.20M
Depreciation 9.19M 7.09M 5.88M 4.08M
Other cashflows from investing activities - - - -
Dividends paid 0.00000M 100.00M 10.00M 25.00M
Change to inventory -3.68000M -1.79800M -0.69300M 0.79M
Change to account receivables -12.88500M -1.95800M -19.73100M -12.22000M
Sale purchase of stock 0.00000M 0.00000M -0.08500M -0.80800M
Other cashflows from financing activities 13.97M 31.60M 1.49M 101.35M
Change to netincome -106.60300M -63.03100M 5.14M 11.09M
Capital expenditures 9.09M 8.11M 6.18M 6.21M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital -2.81900M 20.59M 49.77M 2.71M
Stock based compensation 13.71M 6.48M 7.27M 12.76M
Other non cash items -117.91900M -67.86300M 0.63M 0.13M
Free cash flow 11.49M 27.94M 60.33M 9.92M

Peer Comparison

Sector: Technology Industry: Software - Infrastructure

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CLBT
Cellebrite DI
0.03 0.12% 22.48 - 37.17 11.09 15.38 10.98 93.78
MSFT
Microsoft Corporation
0.09 0.02% 439.42 37.32 29.94 13.03 12.45 13.06 24.59
ORCL
Oracle Corporation
0.48 0.28% 172.20 29.34 18.66 5.55 74.06 7.10 18.13
ADBE
Adobe Systems Incorporated
3.81 0.85% 451.75 46.32 26.81 11.51 16.73 11.55 31.20
PANW
Palo Alto Networks Inc
-0.7392 0.39% 188.77 44.57 45.05 11.98 20.70 11.82 77.11

Reports Covered

Stock Research & News

Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.

Cellebrite DI

94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602

Key Executives

Name Title Year Born
Mr. Yossi Carmil Founder, CEO & Director 1967
Ms. Dana Gerner Chief Financial Officer 1967
Mr. Arnon Zilberman Exec. VP of Information Systems & Operations NA
Mr. Ronnen Armon Chief Products & Technologies Officer 1963
Anat Earon-Heilborn VP of Investor Relations NA
Ms. Ayala Berler Shapira Gen. Counsel NA
Adam Jaffe VP of Global Communications NA
Ms. Osnat Tirosh Chief People & Corp. Devel. Officer 1969
Ms. Lisa Cole Chief Marketing Officer NA
Mr. Leeor Ben-Peretz Chief Strategy Officer 1976

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.